Clinical Trial

Evaluation of the Success of Artificial Intelligence Models in Interpreting Arterial Waveform Analysis Data

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 4, 2025 (before its estimated August 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to evaluate the ability of artificial intelligence (AI) models to interpret arterial waveform analysis data obtained from a hemodynamic monitoring system in adult patients undergoing elective surgery. The main questions it aims to answer are: Can AI models (ChatGPT-4 and Gemini 2.0) accurately detect hemodynamic abnormalities in arterial waveform data? How well do AI-generated diagnoses align with expert anesthesiologist assessments? Are AI-generated treatment recommendations clinically appropriate? Participants will: Undergo standard hemodynamic monitoring with an arterial waveform analysis device (MostCare). Have their anonymized hemodynamic data analyzed by AI models for abnormality detection, diagnosis suggestions, and treatment recommendations. Have AI-generated results reviewed and validated by experienced anesthesiologists. This study aims to assess whether AI models can serve as decision-support tools in perioperative and critical care settings by improving the interpretation of complex hemodynamic data, potentially enhancing patient safety, diagnostic accuracy, and clinical efficiency.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-02-10; most recent amendment 2025-03-03.
Status change: Not Yet Recruiting → Recruiting 2025-03-03
Trial Details
NCT Number NCT06828575
Lead Sponsor Kanuni Sultan Suleyman Training and Research Hospital
Conditions Hemodynamic Instability
Enrollment 145 participants
Start Date 2025-02-15
Primary Completion 2025-08-15 (estimated)
Study Completion 2025-08-16 (estimated)
Updated on ClinicalTrials.gov 2025-03-04